This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Scholar Rock, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Frederick C. Streich
Introduction
Frederick C. Streich is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Frederick C. Streich holds a patent for "Selective and potent inhibitory antibodies of myostatin activation." This patent relates to antibodies and antigen-binding fragments that specifically bind to pro/latent myostatin and their various uses. This invention has the potential to impact treatments related to muscle growth and related disorders.
Career Highlights
Streich is currently associated with Scholar Rock, Inc., a company dedicated to advancing transformative medicines for patients with serious diseases. His role at Scholar Rock allows him to leverage his expertise in antibody development to create impactful therapies.
Collaborations
Frederick has collaborated with talented individuals such as Christopher Chapron and Kaleigh Canonico. These partnerships enhance the innovative environment at Scholar Rock, fostering the development of groundbreaking therapies.
Conclusion
Frederick C. Streich's contributions to biotechnology through his patent and work at Scholar Rock, Inc. exemplify the spirit of innovation in the field. His efforts in developing selective antibodies are paving the way for new therapeutic options.